ATE519757T1 - 3 hydroxyflavon-derivate zur erkennung und quantifizierung von zell-apoptosen - Google Patents

3 hydroxyflavon-derivate zur erkennung und quantifizierung von zell-apoptosen

Info

Publication number
ATE519757T1
ATE519757T1 AT06842347T AT06842347T ATE519757T1 AT E519757 T1 ATE519757 T1 AT E519757T1 AT 06842347 T AT06842347 T AT 06842347T AT 06842347 T AT06842347 T AT 06842347T AT E519757 T1 ATE519757 T1 AT E519757T1
Authority
AT
Austria
Prior art keywords
cell apoptosis
quantification
derivatives
detection
hydroxyflavone
Prior art date
Application number
AT06842347T
Other languages
English (en)
Inventor
Yves Mely
Andrey Klymchenko
Oleksandr Demchenko
Vasyl Shynkar
Original Assignee
Centre Nat Rech Scient
Univ Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Pasteur filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE519757T1 publication Critical patent/ATE519757T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
AT06842347T 2005-10-11 2006-10-11 3 hydroxyflavon-derivate zur erkennung und quantifizierung von zell-apoptosen ATE519757T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72477205P 2005-10-11 2005-10-11
PCT/IB2006/003911 WO2007057782A2 (en) 2005-10-11 2006-10-11 3 -hydroxyflavone derivatives for the detection and the quantification of cell apoptosis

Publications (1)

Publication Number Publication Date
ATE519757T1 true ATE519757T1 (de) 2011-08-15

Family

ID=38008234

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06842347T ATE519757T1 (de) 2005-10-11 2006-10-11 3 hydroxyflavon-derivate zur erkennung und quantifizierung von zell-apoptosen

Country Status (6)

Country Link
US (1) US7880021B2 (de)
EP (1) EP1948633B1 (de)
JP (1) JP5030961B2 (de)
AT (1) ATE519757T1 (de)
CA (1) CA2624772C (de)
WO (1) WO2007057782A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6262229A (ja) * 1985-09-13 1987-03-18 Minolta Camera Co Ltd 多分割測光装置を有するカメラ
SI2350075T1 (sl) 2008-09-22 2014-06-30 Array Biopharma, Inc. Substituirane imidazo (1,2b)piridazinske spojine kot Trk kinazni inhibitorji
CN102264736B (zh) 2008-10-22 2013-08-14 阵列生物制药公司 作为TRK激酶抑制剂的取代的吡唑并[1,5-a]嘧啶化合物
AR077468A1 (es) 2009-07-09 2011-08-31 Array Biopharma Inc Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
BR122019024201B1 (pt) 2010-05-20 2021-08-03 Array Biopharma Inc Composto macrocíclico como inibidores de trk quinase, seu uso, e composição farmacêutica
US8852274B2 (en) 2011-06-24 2014-10-07 Advanced Vision Science, Inc. Composite ophthalmic devices and methods with incident light modifying properties
UA105278C2 (ru) 2012-09-06 2014-04-25 Інститут Біології Клітини Нан України Способ получения каталитически активных антител (абзимов) с сиалидазной активностью
JP6322702B2 (ja) * 2013-10-10 2018-05-09 チュビタック (ターキー ビリムセル ヴィ テクノロジク アラスティルマ クルム)Tubitak (Turkiye Bilimsel Ve Teknolojik Arastirma Kurumu) 蛍光色素分子である3−ヒドロキシフラボン
US9868715B2 (en) * 2014-04-19 2018-01-16 The Board Of Regents Of The University Of Texas Systems Apigenin analogs, compositions, and methods related thereto
TWI746426B (zh) 2014-11-16 2021-11-21 美商亞雷生物製藥股份有限公司 (S)-N-(5-((R)-2-(2,5-二氟苯基)-吡咯啶-1-基)-吡唑并[1,5-a]嘧啶-3-基)-3-羥基吡咯啶-1-甲醯胺硫酸氫鹽結晶型
EP3368039A1 (de) 2015-10-26 2018-09-05 The Regents of The University of Colorado, A Body Corporate Punktmutationen bei trk-inhibitor-resistentem krebs und zugehörige verfahren
UA125026C2 (uk) 2016-04-04 2021-12-29 Локсо Онколоджі, Інк. РІДКІ КОМПОЗИЦІЇ (S)-N-(5-((R)-2-(2,5-ДИФТОРФЕНІЛ)ПІРОЛІДИН-1-ІЛ)ПІРАЗОЛО[1,5-a]ПІРИМІДИН-3-ІЛ)-3-ГІДРОКСИПІРОЛІДИН-1-КАРБОКСАМІДУ
UA125025C2 (uk) 2016-04-04 2021-12-29 Локсо Онколоджі, Інк. Способи лікування дитячих ракових захворювань
MX392604B (es) 2016-05-18 2025-03-24 Array Biopharma Inc Procesos para la preparacion de (s)-n-(5-((r)-2-(2,5-difluorofenil)pirrolidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidin-1-carboxamida y sales del mismo.
JOP20190092A1 (ar) 2016-10-26 2019-04-25 Array Biopharma Inc عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
JOP20190213A1 (ar) 2017-03-16 2019-09-16 Array Biopharma Inc مركبات حلقية ضخمة كمثبطات لكيناز ros1
AU2021342568B2 (en) 2020-09-21 2025-04-03 Landos Biopharma, Inc. Nlrx1 ligands
KR20240032892A (ko) * 2021-07-01 2024-03-12 나노템퍼 테크놀로지스 게엠베하 형광 입자의 비율계량 특성화 방법 및 장치
CN114957299B (zh) * 2022-02-24 2024-04-09 川北医学院 用于检测凋亡细胞的荧光探针及其制备方法
CN115028652B (zh) * 2022-02-24 2024-04-05 川北医学院 用于卵巢癌光动力诊疗的高光敏性荧光探针
JP2025513455A (ja) 2022-04-22 2025-04-24 バーテックス ファーマシューティカルズ インコーポレイテッド 疼痛の治療のためのヘテロアリール化合物
CN119080688B (zh) * 2024-10-31 2025-03-14 山东第一医科大学第三附属医院(山东省医学科学院附属医院) 一种利用极性响应比率型检测细胞膜完整性的荧光探针及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022731A1 (en) * 2002-04-26 2004-02-05 Alexei Bogdanov In vivo imaging of apoptosis

Also Published As

Publication number Publication date
CA2624772A1 (en) 2007-05-24
WO2007057782A3 (en) 2007-08-30
US7880021B2 (en) 2011-02-01
JP2009511566A (ja) 2009-03-19
WO2007057782A2 (en) 2007-05-24
CA2624772C (en) 2011-11-29
JP5030961B2 (ja) 2012-09-19
US20090269793A1 (en) 2009-10-29
EP1948633B1 (de) 2011-08-10
EP1948633A2 (de) 2008-07-30

Similar Documents

Publication Publication Date Title
EP3102706A4 (de) Hochempfindliche erkennung eines extrem niedrigen pegels biologischer analyten mit elektrochemischer signalverstärkung und biosensor
ATE478559T1 (de) Nachweis von protease und protease-aktivität mithilfe einer einzel-nanosteigerungs-sers-sonde
SG171582A1 (en) Apparatus and method for electrochemical detection
DE602006015793D1 (de) Proteolipidmembran und lipidmembranen-biosensor
MX2018011832A (es) Metodos y composiciones para uso en diagnostico de pacientes con cancer.
EP2189519A4 (de) Zellkulturinstrument und zellkuklturverfahren damit
EA200700094A1 (ru) Способ промышленной очистки образцов клеток для получения терапевтических протеинов
BR112012016119B1 (pt) método de detecção de células em uma amostra, dispositivo unitário de preparação e detecção de amostra e kit
EP1960532A4 (de) System zum zählen von bakterien und zur bestimmung von deren anfälligkeit gegenüber antibiotika
ATE533558T1 (de) Phiolen und vorrichtung zur gewinnung einer musterprobe
UY29853A1 (es) Derivados de diacilindazol como inhibidores de lipasas y fosfolipasas-
CR20110216A (es) Derivados de ácido 1-amino-2-ciclobutiletilborónico
BR112014020083A8 (pt) Dispositivos indicadores biológicos de esterilização e métodos de uso
EA201101563A1 (ru) Безколбовый спектрометр
EP4386361C0 (de) Vorrichtung zur erkennung von defekten des aussehens von batteriezellen und detektionsvorrichtung
BR112013007156A2 (pt) sistemas e métodos para estabilidade aperfeiçoada de sensores eletroquímicos
WO2012067970A3 (en) Transcriptional repression leading to parkinson's disease
BRPI0819854A2 (pt) Enumeração e caracterização automatizada de células de melanoma circulantes no sangue
EA201370070A1 (ru) СПОСОБ ДЕТЕКЦИИ, ДИФФЕРЕНЦИАЦИИ И КВАНТИФИКАЦИИ ПОПУЛЯЦИЙ Т-КЛЕТОК С ИСПОЛЬЗОВАНИЕМ КОЛИЧЕСТВЕННОЙ ПЦР С ОБРАТНОЙ ТРАНСКРИПЦИЕЙ В РЕАЛЬНОМ ВРЕМЕНИ (ОТ-колПЦР РВ)
EP2470898A4 (de) Bestimmung der empfindlichkeit von zellen für b-raf-hemmer-behandlung durch erkennung von kras-mutationen und rtk-expressionsspiegeln
DK1989544T3 (da) T-celle-testmetode
EA200601562A1 (ru) Сокристаллы госсипола и их применение
ATE549638T1 (de) 13c-mr-bildgebung oder spektroskopie von zelltod
DE602007013695D1 (de) Leuchtende stammzellen und ihre verwendung
UY29872A1 (es) Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties